TRPM2
Basic information
Region (hg38): 21:44350163-44443081
Previous symbols: [ "TRPC7" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TRPM2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 17 | |||||
missense | 115 | 21 | 12 | 148 | ||
nonsense | 3 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 3 | 1 | 4 | |||
non coding | 32 | 33 | ||||
Total | 0 | 0 | 116 | 32 | 55 |
Variants in TRPM2
This is a list of pathogenic ClinVar variants found in the TRPM2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
21-44353843-G-T | not specified | Uncertain significance (Mar 02, 2023) | ||
21-44353851-G-A | not specified | Uncertain significance (Dec 02, 2022) | ||
21-44354664-C-T | not specified | Uncertain significance (Nov 21, 2022) | ||
21-44364116-A-G | not specified | Uncertain significance (Mar 29, 2023) | ||
21-44364140-C-A | not specified | Uncertain significance (Dec 22, 2023) | ||
21-44364188-G-A | not specified | Uncertain significance (Jul 07, 2022) | ||
21-44364207-G-A | Benign (Dec 31, 2019) | |||
21-44364211-C-T | not specified | Uncertain significance (Aug 11, 2022) | ||
21-44364252-C-T | Likely benign (Feb 25, 2018) | |||
21-44364258-G-A | Benign (Dec 31, 2019) | |||
21-44366485-G-G | Benign (Jun 19, 2021) | |||
21-44366769-C-T | Uncertain significance (Feb 01, 2021) | |||
21-44366785-G-A | not specified | Uncertain significance (Mar 21, 2023) | ||
21-44366787-G-A | Likely benign (Dec 31, 2019) | |||
21-44366826-G-A | Benign (Dec 31, 2019) | |||
21-44366874-A-G | not specified | Uncertain significance (Jun 17, 2024) | ||
21-44369179-G-T | not specified | Uncertain significance (Jan 03, 2024) | ||
21-44369195-G-C | not specified | Uncertain significance (Jun 09, 2022) | ||
21-44369273-G-T | not specified | Uncertain significance (Nov 30, 2022) | ||
21-44369302-T-G | not specified | Uncertain significance (May 20, 2024) | ||
21-44369320-C-A | not specified | Uncertain significance (Dec 20, 2023) | ||
21-44369320-C-G | not specified | Uncertain significance (Mar 06, 2023) | ||
21-44369351-C-A | Benign/Likely benign (Nov 01, 2022) | |||
21-44375845-G-A | not specified | Uncertain significance (Sep 01, 2021) | ||
21-44375899-AACC-A | Likely benign (Jun 13, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TRPM2 | protein_coding | protein_coding | ENST00000397928 | 32 | 92919 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
8.96e-44 | 0.00000727 | 124953 | 3 | 792 | 125748 | 0.00317 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.335 | 988 | 959 | 1.03 | 0.0000646 | 9817 |
Missense in Polyphen | 310 | 299.15 | 1.0363 | 3043 | ||
Synonymous | -3.29 | 516 | 429 | 1.20 | 0.0000326 | 2943 |
Loss of Function | 0.720 | 70 | 76.8 | 0.911 | 0.00000370 | 827 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00617 | 0.00609 |
Ashkenazi Jewish | 0.0113 | 0.0111 |
East Asian | 0.00146 | 0.00141 |
Finnish | 0.000562 | 0.000554 |
European (Non-Finnish) | 0.00294 | 0.00287 |
Middle Eastern | 0.00146 | 0.00141 |
South Asian | 0.00403 | 0.00389 |
Other | 0.00434 | 0.00424 |
dbNSFP
Source:
- Function
- FUNCTION: Isoform 1: Nonselective, voltage-independent cation channel that mediates Na(+) and Ca(2+) influx, leading to increased cytoplasmic Ca(2+) levels (PubMed:11960981, PubMed:12594222, PubMed:11385575, PubMed:11509734, PubMed:11804595, PubMed:15561722, PubMed:16601673, PubMed:19171771, PubMed:20660597, PubMed:27383051, PubMed:27068538). Extracellular calcium passes through the channel and increases channel activity by binding to the cytoplasmic domain and stabilizing the channel in an open conformation (PubMed:19171771). Also contributes to Ca(2+) release from intracellular stores in response to ADP-ribose (PubMed:19454650). Plays a role in numerous processes that involve signaling via intracellular Ca(2+) levels (Probable). Besides, mediates the release of lysosomal Zn(2+) stores in response to reactive oxygen species, leading to increased cytosolic Zn(2+) levels (PubMed:25562606, PubMed:27068538). Activated by moderate heat (35 to 40 degrees Celsius) (PubMed:16601673). Activated by intracellular ADP-ribose, beta-NAD (NAD(+)) and similar compounds, and by oxidative stress caused by reactive oxygen or nitrogen species (PubMed:11960981, PubMed:11385575, PubMed:11509734, PubMed:11804595, PubMed:15561722, PubMed:16601673, PubMed:19171771, PubMed:27383051, PubMed:27068538). The precise physiological activators are under debate; the true, physiological activators may be ADP-ribose and ADP-ribose-2'-phosphate (PubMed:20650899, PubMed:25918360). Activation by ADP-ribose and beta-NAD is strongly increased by moderate heat (35 to 40 degrees Celsius) (PubMed:16601673). Likewise, reactive oxygen species lower the threshold for activation by moderate heat (37 degrees Celsius) (PubMed:22493272). Plays a role in mediating behavorial and physiological responses to moderate heat and thereby contributes to body temperature homeostasis. Plays a role in insulin secretion, a process that requires increased cytoplasmic Ca(2+) levels (By similarity). Required for normal IFNG and cytokine secretion and normal innate immune immunity in response to bacterial infection. Required for normal phagocytosis and cytokine release by macrophages exposed to zymosan (in vitro). Plays a role in dendritic cell differentiation and maturation, and in dendritic cell chemotaxis via its role in regulating cytoplasmic Ca(2+) levels (By similarity). Plays a role in the regulation of the reorganization of the actin cytoskeleton and filopodia formation in response to reactive oxygen species via its role in increasing cytoplasmic Ca(2+) and Zn(2+) levels (PubMed:27068538). Confers susceptibility to cell death following oxidative stress (PubMed:12594222, PubMed:25562606). {ECO:0000250|UniProtKB:Q91YD4, ECO:0000269|PubMed:11385575, ECO:0000269|PubMed:11509734, ECO:0000269|PubMed:11804595, ECO:0000269|PubMed:11960981, ECO:0000269|PubMed:12594222, ECO:0000269|PubMed:15561722, ECO:0000269|PubMed:16601673, ECO:0000269|PubMed:19171771, ECO:0000269|PubMed:19454650, ECO:0000269|PubMed:20650899, ECO:0000269|PubMed:20660597, ECO:0000269|PubMed:22493272, ECO:0000269|PubMed:25562606, ECO:0000269|PubMed:25918360, ECO:0000269|PubMed:27068538, ECO:0000269|PubMed:27383051, ECO:0000305}.; FUNCTION: Isoform 3: Lacks cation channel activity and negatively regulates the channel activity of isoform 1. Negatively regulates susceptibility to cell death in reposponse to oxidative stress. {ECO:0000269|PubMed:12594222}.;
- Pathway
- Oxytocin signaling pathway - Homo sapiens (human);NOD-like receptor signaling pathway - Homo sapiens (human);Ectoderm Differentiation;Neutrophil degranulation;Stimuli-sensing channels;Ion channel transport;Innate Immune System;Immune System;Transport of small molecules;Pentose phosphate pathway;TRP channels
(Consensus)
Recessive Scores
- pRec
- 0.0973
Intolerance Scores
- loftool
- 0.797
- rvis_EVS
- 1
- rvis_percentile_EVS
- 90.56
Haploinsufficiency Scores
- pHI
- 0.0958
- hipred
- N
- hipred_score
- 0.342
- ghis
- 0.449
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.606
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Trpm2
- Phenotype
- cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype;
Gene ontology
- Biological process
- temperature homeostasis;dendritic cell chemotaxis;calcium ion transport;response to purine-containing compound;calcium-mediated signaling using intracellular calcium source;sodium ion transmembrane transport;neutrophil degranulation;release of sequestered calcium ion into cytosol;regulation of filopodium assembly;cellular response to hydrogen peroxide;calcium ion transmembrane transport;cellular response to calcium ion;cellular response to purine-containing compound;cellular response to temperature stimulus;zinc ion transmembrane transport;dendritic cell differentiation;calcium ion transmembrane import into cytosol;calcium ion import across plasma membrane;regulation of actin cytoskeleton reorganization
- Cellular component
- lysosome;lysosomal membrane;plasma membrane;integral component of plasma membrane;cytoplasmic vesicle membrane;specific granule membrane;cell projection;perikaryon;tertiary granule membrane;ficolin-1-rich granule membrane
- Molecular function
- cation channel activity;calcium channel activity;sodium channel activity;calcium ion binding;calcium-release channel activity;hydrolase activity;ligand-gated calcium channel activity